Clear Street’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Clear Street’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.43K	Hold	34,082	–	–	﹤0.01%	1274
2026 Q1	$2.55K	Buy	34,082 +100	+0.3%	+$8	﹤0.01%	1024
2025 Q4	$1.7K	Hold	33,982	–	–	﹤0.01%	859
2025 Q3	$1.76K	Hold	33,982	–	–	﹤0.01%	760
2025 Q2	$1.61K	Buy	33,982 +5,291	+18%	+$267	﹤0.01%	595
2025 Q1	$2.21K	Buy	28,691 +100	+0.3%	+$9	﹤0.01%	460
2024 Q4	$2.63K	Hold	28,591	–	–	﹤0.01%	451
2024 Q3	$1.84K	Sell	28,591 -100	-0.3%	-$8	﹤0.01%	562
2024 Q2	$1.98K	Buy	28,691 +100	+0.3%	+$5	﹤0.01%	602
2024 Q1	$1.9K	Hold	28,591	–	–	﹤0.01%	582
2023 Q4	$858	Hold	28,591	–	–	﹤0.01%	642
2023 Q3	$6.87K	Sell	28,591 -300	-1%	-$50	﹤0.01%	613
2023 Q2	$1.6K	Buy	28,891 +1,200	+4%	+$82	﹤0.01%	1005
2023 Q1	$2.83K	Buy	27,691 +100	+0.4%	+$7	﹤0.01%	791
2022 Q4	$1K	Buy	27,591 +9,841	+55%	+$823	﹤0.01%	923
2022 Q3	$1K	Buy	17,750 +17,650	+17,650%	+$2.99K	﹤0.01%	1034
2022 Q2	$0	Buy	+100	New	+$22	﹤0.01%	1034

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clear Street's ESLAW Position: Q2 2026 in Review

Clear Street held its Estrella Immunopharma Warrant (ESLAW) position steady in Q2 2026 at 34,082 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Clear Street first reported a position in ESLAW in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.87K in Q3 2023. 8 funds tracked by Wall St. Rank hold ESLAW as of Q2 2026.

Clear Street held 34,082 shares of Estrella Immunopharma Warrant worth $4.43K as of Q2 2026.
Clear Street left its Estrella Immunopharma Warrant share count unchanged in Q2 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1274 holding.
Clear Street first reported a position in Estrella Immunopharma Warrant in Q2 2022 and has held it in 17 quarters since.
Clear Street's Estrella Immunopharma Warrant position peaked at $6.87K in Q3 2023.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.